Page last updated: 2024-08-16

technetium tc 99m sestamibi and Multiple Myeloma

technetium tc 99m sestamibi has been researched along with Multiple Myeloma in 62 studies

Research

Studies (62)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (12.90)18.2507
2000's41 (66.13)29.6817
2010's11 (17.74)24.3611
2020's2 (3.23)2.80

Authors

AuthorsStudies
Amorim, BJ; Carvalheira, JBC; de Souza, CA; Delamain, MT; Etchebehere, ECSC; Lima, MCL; Lorand-Metze, I; Miranda, ECM; Mosci, C; Oliveira, GB; Pericole, FV; Ramos, CD; Santos, AO; Takahashi, MES1
Baghdadi, Y; Di Dea, MT; Moadel, RM; Travin, MI1
Bulzan, J; Byun, K; Revels, J1
Catalano, L; Cerchione, C; De Luca, S; Del Vecchio, S; Fonti, R; Pace, L; Pane, F; Salvatore, B; Salvatore, M1
Ghaedian, T; Haghighatafshar, M; Mortazavi, S1
Bhave, A; Lele, RD; Luthra, K1
Bhambhvani, P; Farag, AA; Hage, FG; Patel, H1
Bacovsky, J; Kaminek, M; Koranda, P; Myslivecek, M; Nekula, J; Scudla, V1
Beksac, M; Comenzo, RL; Dimopoulos, M; Durie, BG; Kumar, S; Lokhorst, H; Moulopoulos, LA; Niesvizky, R; Rajkumar, SV; Sezer, O; Siegel, D; Terpos, E; Tosi, P1
Chakraborty, K; Hamati, AK; Hammad, AN; Ismail, HM; Jenigiri, B; Smalligan, RD1
Baldini, L; Calori, R; Carletto, M; Castellani, M; Dellavedova, L; Gerundini, P; Longari, V; Soligo, D1
Carty, F; Murray, JG; Shortt, CP1
Bacovsky, J; Buriankova, E; Koranda, P; Minarik, J; Myslivecek, M; Pika, T; Scudla, V; Zapletalova, J1
Bacovský, J; Buriánková, E; Formánek, R; Koranda, P; Minarík, J; Myslivecek, M; Scudla, V; Zapletalová, J1
Bartel, T; Brown, TL; De Blanche, L; Jones-Jackson, LB; Walker, RC1
Gatta, G; Prisco, MR; Scialpi, M; Vaccaro, A1
De Renzo, A; De Rosa, G; Karadimitris, A; Notaro, R; Rotoli, B1
Cerino, M; Demaria, S; Eybalin, MC; Lette, J; Levasseur, A1
Ak, I; Aslan, V; Gülbaş, Z; Vardareli, E1
Alexandrakis, MG; Karkavitsas, N; Kyriakou, DS; Malliaraki, N; Passam, FH; Vlachonikolis, IG1
Akbunar, T; Alper, E; Demiray, M; Evrensel, T; Gurel, M; Ozkocaman, V1
Andretta, C; Annunziata, G; Catalano, L; Fonti, R; Pace, L; Rotoli, B1
Athanasoulis, T; Dimopoulos, MA; Koutsikos, J; Moulopoulos, LA; Tsiouris, S; Zerva, C1
Del Vecchio, S; Pace, L; Salvatore, M2
Blum, R; Hicks, RJ; Mileshkin, L; Patrikeos, A; Prince, HM; Seymour, JF1
Catalano, L; De Renzo, A; Del Vecchio, S; Fonti, R; Pace, L; Rotoli, B; Salvatore, M; Zannetti, A1
Anagnostopoulos, A; Athanasoulis, T; Dimopoulos, MA; Koutsikos, J; Passadi, M; Velidaki, A; Zerva, C1
Donahue, L; John, V; Margouleff, D; Patel, N; Talwar, A1
Bacovsky, J; Myslivecek, M; Nekula, J; Scudla, V; Vytrasová, M1
Alba, PR; Banzo, JB; Dourdil Sahún, MV; Martín, MG; Olave, P; Romero Colás, MS1
Andretta, C; Buonanno, MT; Catalano, L; De Rosa, G; Del Vecchio, S; Pace, L; Paone, G; Rotoli, B; Salvatore, B1
Andretta, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Nuzzo, C; Fonti, R; Pace, L; Rotoli, B; Salvatore, B; Salvatore, M1
Balleari, E; Carletto, M; Clavio, M; Ghio, R; Gobbi, M; Grosso, M; Morbelli, S; Peschiera, F; Piccardo, A; Rebella, L; Tommasi, L; Villa, G1
Agostini, V; Ascoli, G; Berbellini, A; Brianzoni, E; Brunori, M; Cambioli, F; Catarini, M; Corvatta, L; Gradari, M; Isidori, A; Leoni, P; Marconi, M; Mele, A; Nonni, M; Offidani, M; Spinelli, A; Visani, G1
Califano, C; Caparrotti, G; Catalano, L; Del Vecchio, S; Fonti, R; Martorelli, C; Pace, L; Petruzziello, F; Rotoli, B; Salvatore, B; Segreto, S1
Abildgaard, N; D'Sa, S; Hall-Craggs, M; Shaw, P; Tighe, J1
Bakir, B; Berberoglu, K; Besisik, SK; Erten, N; Saka, B; Turkmen, C; Unal, S; Yekeler, E1
Catalano, L; Del Vecchio, S; Fonti, R; Liuzzi, R; Pace, L; Petruzziello, F; Quarantelli, M; Rotoli, B; Salvatore, B; Salvatore, M; Segreto, S; Sirignano, C1
Chowdhury, FU; Scarsbrook, AF1
Cavalli, F; Ceriani, L; Delaloye, AB; Giovanella, L; Taborelli, M; Zucca, E1
Adams, BK; Fataar, A; Nizami, MA1
Fuerst, MM; Giles, FJ; Gupta, PK; Kusuanco, DA; Lawrence, GN; Lim, SW; Look, RM; Waxman, AD1
Biassoni, L; Britton, KE; Kaleva, N; Kouykin, V; Malpas, JS; Tirovola, EB1
el-Shirbiny, AM; Imbriaco, M; Larson, SM; Macapinlac, H; Michaeli, J; Yeung, H1
Califano, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Gennaro, F; Pace, L; Pinto, A; Rotoli, B; Salvatore, M1
Hasegawa, Y; Hashizume, T; Hiraoka, A; Maeda, T; Masaoka, T; Nakamura, H; Teshima, H; Wakasugi, S1
Catalano, L; de Renzo, A; del Vecchio, S; Di Gennaro, F; Pace, L; Pinto, AM; Rotoli, B; Salvatore, M1
Califano, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Gennaro, F; Fonti, R; Pace, L; Pinto, AM; Rotoli, B; Salvatore, M1
Cavanaugh, D; Fisher, C; Houpt, L; Howe, K; Kashlan, B; Longa, G; Stark, L; Vehec, A1
De Rosa, G; Del Vecchio, S; Pezzullo, L1
Califano, C; Catalano, L; De Renzo, A; Di Gennaro, F; Pace, L; Pinto, AM1
Agnese, G; Balleari, E; Carletto, M; Clavio, M; Ferrando, F; Garrè, S; Ghio, R; Ghirlanda, P; Gobbi, M; Mariani, G; Villa, G1
Cho, IH; Chun, KA; Hayashida, K; Hyun, MS; Lee, HW; Lee, KH; Won, KC1
Califano, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Gennaro, F; Fonti, R; Pace, L; Rotoli, B; Salvatore, M; Zannetti, A1
Borrelli, G; Califano, C; Catalano, L; De Renzo, A; Del Vecchio, S; Di Gennaro, F; Pace, L; Rotoli, B; Salvatore, M; Sica, G; Tedesco, N1
Alexandrakis, MG; Karkavitsas, N; Koukouraki, S; Kyriakou, DS; Passam, F1
Bettini, D; Fabris, P; Franzelin, F; Gebert, U; Mitterer, M; Osele, L; Svaldi, M; Tappa, C1
Blocklet, D; Feremans, W; Kentos, A; Schoutens, A1
Lin, WY; Wang, SJ1
Aktolun, C; Arslan, A; Berk, F; Demir, H; Erdincler, O; Hacihanefioglu, A; Isgoren, S1
Alexandrakis, MG; Christophoridou, AV; Karkavitsas, N; Kyriakou, DS; Malliaraki, N; Passam, FH1

Reviews

6 review(s) available for technetium tc 99m sestamibi and Multiple Myeloma

ArticleYear
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
    Leukemia, 2009, Volume: 23, Issue:9

    Topics: Absorptiometry, Photon; Bone Neoplasms; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Prognosis; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed

2009
The role of whole-body imaging in the diagnosis, staging, and follow-up of multiple myeloma.
    Seminars in musculoskeletal radiology, 2010, Volume: 14, Issue:1

    Topics: Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Whole Body Imaging

2010
Imaging of multiple myeloma and related plasma cell dyscrasias.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:7

    Topics: Bone and Bones; Bone Marrow Neoplasms; Bone Neoplasms; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Paraproteinemias; POEMS Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Whole Body Imaging

2012
[New diagnostic imaging approaches in multiple myeloma].
    Recenti progressi in medicina, 2012, Volume: 103, Issue:11

    Topics: Diagnostic Imaging; Humans; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2012
Multiple myeloma cured by conventional chemotherapy: a report and a review.
    Leukemia & lymphoma, 2002, Volume: 43, Issue:4

    Topics: Adult; Bone and Bones; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Technetium Tc 99m Sestamibi

2002
Hyperparathyroidism accompanying multiple myeloma.
    Clinical nuclear medicine, 2005, Volume: 30, Issue:8

    Topics: Adenoma; Aged; Female; Humans; Hypercalcemia; Hyperparathyroidism; Multiple Myeloma; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2005

Trials

14 trial(s) available for technetium tc 99m sestamibi and Multiple Myeloma

ArticleYear
Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Nuclear medicine review. Central & Eastern Europe, 2008, Volume: 11, Issue:1

    Topics: Antineoplastic Agents; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome

2008
Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Prognosis; Radionuclide Imaging; Survival Analysis; Technetium Tc 99m Sestamibi

2010
Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
    Annals of hematology, 2003, Volume: 82, Issue:2

    Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Aged; Antigens, CD; Biomarkers; Bone Marrow; Female; Flow Cytometry; Humans; Male; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Neoplasm Invasiveness; Plasma Cells; Predictive Value of Tests; Proteoglycans; Radionuclide Imaging; Severity of Illness Index; Syndecan-1; Syndecans; Technetium Tc 99m Sestamibi

2003
99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
    Nuclear medicine communications, 2003, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Bone Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Whole-Body Counting

2003
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.
    Cancer biotherapy & radiopharmaceuticals, 2004, Volume: 19, Issue:2

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Diagnostic Imaging; Drug Resistance, Multiple; Female; Humans; Male; Middle Aged; Multiple Myeloma; Sensitivity and Specificity; Technetium Tc 99m Sestamibi

2004
Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma.
    Neoplasma, 2005, Volume: 52, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease Progression; Female; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2005
Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2005, Volume: 49, Issue:3

    Topics: Antineoplastic Agents; Disease-Free Survival; Female; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Multiple Myeloma; Prognosis; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome

2005
Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
    Journal of experimental & clinical cancer research : CR, 2005, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Remission Induction; Stem Cell Transplantation; Technetium Tc 99m Sestamibi

2005
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis.
    Annals of hematology, 2007, Volume: 86, Issue:6

    Topics: Aged; Diphosphonates; Fluorodeoxyglucose F18; Humans; Jaw Diseases; Multiple Myeloma; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2007
Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Annals of hematology, 2007, Volume: 86, Issue:11

    Topics: Adult; Aged; beta 2-Microglobulin; Biomarkers; Bone Marrow; Female; Humans; Immunoglobulin M; L-Lactate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi

2007
Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
    European journal of nuclear medicine, 1998, Volume: 25, Issue:7

    Topics: Antibodies, Monoclonal; Bone Marrow; Bone Marrow Neoplasms; Female; Humans; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting

1998
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
    Haematologica, 1999, Volume: 84, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

1999
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:2

    Topics: Aged; Autoradiography; Bone Marrow; Bone Marrow Cells; Female; Humans; Male; Middle Aged; Multiple Myeloma; Plasma Cells; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting

2001
Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:3

    Topics: Aged; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting

2001

Other Studies

42 other study(ies) available for technetium tc 99m sestamibi and Multiple Myeloma

ArticleYear
99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma.
    Nuclear medicine communications, 2020, Volume: 41, Issue:10

    Topics: Adult; Aged; Biological Transport; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Sestamibi

2020
A potential artifact to consider when performing
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:6

    Topics: Artifacts; Humans; Multiple Myeloma; Perfusion; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2022
Progression of Multiple Myeloma Detected on Cardiac Scintigraphy with 99mTc Sestamibi.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:7

    Topics: Aged; Heart; Humans; Incidental Findings; Male; Multiple Myeloma; Myocardial Perfusion Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2018
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed

2015
Multiple Myeloma and Abdominal Aortic Aneurysm on Myocardial Perfusion Raw Images.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:11

    Topics: Aged; Aortic Aneurysm, Abdominal; Humans; Incidental Findings; Male; Multiple Myeloma; Myocardial Perfusion Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2015
Tc 99m Sestamibi Scanning in Multiple Myeloma--a New look with SPECT-CT.
    The Journal of the Association of Physicians of India, 2014, Volume: 62, Issue:9

    Topics: Female; Follow-Up Studies; Humans; Male; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasmacytoma; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Remission Induction; Technetium Tc 99m Sestamibi

2014
Incidental detection of abnormal
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:4

    Topics: Aged; Humans; Male; Multiple Myeloma; Myocardial Perfusion Imaging; Radiopharmaceuticals; Rib Cage; Sternum; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2017
A bone to pick about chest pain.
    Southern medical journal, 2009, Volume: 102, Issue:9

    Topics: Aged; Blood Protein Electrophoresis; Bone Marrow Examination; Chest Pain; Exercise Test; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Technetium Tc 99m Sestamibi

2009
The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:1

    Topics: Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple Myeloma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi

2010
[18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2010, Volume: 23, Issue:5

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed

2010
Serendipitous diagnosis of multiple myeloma during sestamibi myocardial perfusion imaging.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:11

    Topics: Aged; Bone Neoplasms; Diagnosis, Differential; Heart; Humans; Leukemia; Lymphoma; Male; Multiple Myeloma; Myocardial Infarction; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting

2002
Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99m-sestaMIBI scintigraphy and other biochemical markers of disease activity.
    Hematological oncology, 2003, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Bone and Bones; Calcium; Collagen; Collagen Type I; Creatinine; Female; Humans; Immunoglobulin A; Immunoglobulin G; Logistic Models; Male; Middle Aged; Multiple Myeloma; Peptides; Radionuclide Imaging; Radiopharmaceuticals; Skull; Technetium Tc 99m Sestamibi; Time Factors

2003
99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Marrow; Dexamethasone; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thalidomide; Tissue Distribution

2003
Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dexamethasone; Doxorubicin; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Skull; Succimer; Technetium Tc 99m Sestamibi; Tibia; Treatment Outcome; Vincristine

2003
A new role for nuclear medicine in multiple myeloma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:8

    Topics: Humans; Multiple Myeloma; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2003
A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma.
    European journal of haematology, 2004, Volume: 72, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed

2004
Technetium 99m sestamibi in multiple myeloma.
    Radiology, 2005, Volume: 234, Issue:1

    Topics: B-Lymphocytes; Disease Progression; Humans; Incidence; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; United States

2005
Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Treatment Outcome

2005
BaselinTc99-MIBI scanning predicts survival in multiple myeloma and helps to differentiate this disease from monoclonal gammopathy of unknown significance.
    Haematologica, 2005, Volume: 90, Issue:8

    Topics: Diagnosis, Differential; Humans; Multiple Myeloma; Paraproteinemias; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi

2005
Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma.
    Hematology (Amsterdam, Netherlands), 2005, Volume: 10, Issue:4

    Topics: Aged; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Multiple Myeloma; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2005
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
    British journal of haematology, 2007, Volume: 136, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Marrow; C-Reactive Protein; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Invasiveness; Neoplasm Staging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome

2007
Guidelines for the use of imaging in the management of myeloma.
    British journal of haematology, 2007, Volume: 137, Issue:1

    Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Whole-Body Counting

2007
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:2

    Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed

2008
Tc-99m sestamibi uptake mimicking parathyroid adenoma in a patient with primary hyperparathyroidism and occult multiple myeloma.
    Clinical nuclear medicine, 2008, Volume: 33, Issue:3

    Topics: Aged, 80 and over; Female; Humans; Hyperparathyroidism, Primary; Multiple Myeloma; Parathyroid Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2008
99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
    Nuclear medicine communications, 2008, Volume: 29, Issue:6

    Topics: Bone Marrow; Female; Humans; Karyotyping; Male; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi

2008
Technetium-99m-sestamibi uptake in myeloma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:6

    Topics: Female; Humans; Hyperplasia; Immunoglobulin kappa-Chains; Middle Aged; Multiple Myeloma; Parathyroid Glands; Radionuclide Imaging; Technetium Tc 99m Sestamibi

1996
Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation.
    Leukemia & lymphoma, 1996, Volume: 20, Issue:5-6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dexamethasone; Disease Progression; Hematopoietic Stem Cell Transplantation; Humans; Humerus; Male; Mitoxantrone; Multiple Myeloma; Osteolysis; Radionuclide Imaging; Technetium Tc 99m Sestamibi

1996
The use of 99mTc-MIBI scanning in multiple myeloma.
    British journal of cancer, 1996, Volume: 74, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Contrast Media; False Negative Reactions; False Positive Reactions; Humans; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi

1996
Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:8

    Topics: Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed

1997
Tc-99m MIBI localization in bone marrow: a marker of bone marrow malignancy.
    Clinical nuclear medicine, 1998, Volume: 23, Issue:10

    Topics: Adult; Aged; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Prospective Studies; Radionuclide Imaging; Technetium Tc 99m Sestamibi

1998
Tc-99m sestamibi scintigraphy in multiple myeloma.
    Clinical nuclear medicine, 1999, Volume: 24, Issue:2

    Topics: Adult; Aged; Bone and Bones; Bone Marrow Examination; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Skull; Technetium Tc 99m Sestamibi; Whole-Body Counting

1999
Incidental detection of skeletal uptake on sestamibi cardiac images in a patient with previously undiagnosed multiple myeloma.
    Clinical nuclear medicine, 2000, Volume: 25, Issue:3

    Topics: Aged; Aged, 80 and over; Bone and Bones; Dipyridamole; Female; Heart; Heart Failure; Humans; Multiple Myeloma; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2000
Avid (67)Ga uptake in multiple myeloma relapsing after bone marrow transplant.
    Haematologica, 2000, Volume: 85, Issue:7

    Topics: Adult; Bone and Bones; Bone Marrow Transplantation; Fatal Outcome; Gallium Radioisotopes; Humans; Male; Multiple Myeloma; Radionuclide Imaging; Recurrence; Technetium Tc 99m Sestamibi

2000
Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma.
    Haematologica, 2000, Volume: 85, Issue:9

    Topics: Adult; Aged; Diagnosis, Differential; Disease-Free Survival; Female; Humans; Male; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Technetium Tc 99m Sestamibi

2000
Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Haematologica, 2001, Volume: 86, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Radionuclide Imaging; Technetium Tc 99m Sestamibi

2001
Comparison of Tc-99m sestamibi and TI-201 uptake in multiple myeloma.
    Clinical nuclear medicine, 2001, Volume: 26, Issue:3

    Topics: Bone Marrow; Female; Humans; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes

2001
Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
    Annals of hematology, 2001, Volume: 80, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Humans; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi

2001
Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation.
    Annals of hematology, 2001, Volume: 80, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multiple Myeloma; Postoperative Period; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Transplantation, Autologous

2001
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:9

    Topics: Bone Marrow; Humans; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi

2001
Ga-67 scan findings in bone marrow involvement with plasmablastic myeloma and corresponding Tc-99m MIBI images.
    Clinical nuclear medicine, 2001, Volume: 26, Issue:11

    Topics: Aged; Bone Marrow Neoplasms; Gallium Radioisotopes; Humans; Male; Multiple Myeloma; Muscle Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Whole-Body Counting

2001
Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images.
    Annals of nuclear medicine, 2002, Volume: 16, Issue:2

    Topics: Bone and Bones; Humans; Liver; Male; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Technetium Tc 99m Sulfur Colloid; Tomography, Emission-Computed, Single-Photon

2002
Correlation between the uptake of Tc-99m-sestaMIBI and prognostic factors in patients with multiple myeloma.
    Clinical and laboratory haematology, 2002, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Humans; Male; Middle Aged; Multiple Myeloma; Osteolysis; Prognosis; Statistics, Nonparametric; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed

2002